Release Date: 13/08/09 17:28 Summary: Business Update and Board Changes Price Sensitive: Yes Download Document 51.42KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%